儿科抗节律药物和毒性:临床综述
Alexandra T Geanacopoulos1,2, Benjamin Zielonka2,3, Miriam T Fox2
1Division of Emergency Medicine Boston Children's Hospital Boston Massachusetts USA.
Journal of the American College of Emergency Physicians open
|February 19, 2024
概括
儿科抗心律失常药物对于治疗心律障碍至关重要,但可能导致毒性. 紧急诊所医生需要专业知识来识别和治疗这些重要药物的不良影响.
科学领域:
- 儿童心脏病学 儿童心脏病学
- 临床药理学 临床药理学
- 紧急医疗 紧急医疗
背景情况:
- 抗心律失常药物对于治疗儿科心律失常是必不可少的.
- 儿科患者容易受到抗心律失常药物毒性的影响.
- 有效的管理需要急诊医学临床医师的熟练程度.
研究的目的:
- 审查儿童使用抗心律失常药物的情况.
- 详细介绍了常见的儿科抗心律不良药的药理学和不良影响.
- 概述了小儿病患者抗心律失常毒性的毒理治疗方法.
主要方法:
- 现有文献的临床审查.
- 专注于说明,药理学和不良影响.
- 重点是毒理学管理策略.
主要成果:
- 在儿科中常用的抗节律障碍药物有特定的适应症.
- 每种药物都具有独特的药理动力学和药理动力学特征.
- 副作用范围从轻微到危及生命的,需要立即干预.
结论:
- 了解抗不律性药理学是儿童安全使用的关键.
- 在儿科紧急护理中,对毒性的警和及时治疗至关重要.
- 本综述为临床医生管理儿科心律失常及其毒性提供了资源.
相关概念视频
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
996
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
996
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
744
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
744
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
832
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
832
Heart Failure Drugs: Inotropic Agents
588
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
588
Mechanism of Cardiac Arrhythmias
920
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
920


